Acute Undifferentiated Febrile Illness in Hospitalized Adults in Western and Central Provinces, Sri Lanka: High Levels of Coinfections and Clinical Misdiagnoses of Etiology

斯里兰卡西部和中部省份住院成人急性未分化发热性疾病:合并感染率高且病因临床误诊率高

阅读:1

Abstract

Acute undifferentiated febrile illness (AUFI) is an important cause of admission to hospitals in the tropics. We prospectively recruited inpatients with AUFI at three hospitals in Western (n = 540) and Central (n = 260) Provinces, Sri Lanka from January 2022 to May 2023. We obtained clinical and environmental exposure data, blood cultures, acute blood samples, and nasopharyngeal samples at enrollment and convalescent blood samples. Laboratory testing for dengue and influenza viruses, Leptospira, Rickettsia, and Orientia was conducted. Laboratory-confirmed etiology of AUFI was ascertained in 576 of 800 cases (72%). Dengue (n = 189/540), leptospirosis (n = 173/540), and scrub typhus/rickettsial infection (n = 57/540) were principal etiologies of AUFI in Western Province. Dengue (n = 69/260), leptospirosis (n = 61/260), and scrub typhus/rickettsial infection (n = 35/260) were causes of AUFI in Central Province. In both provinces, 82 of 800 cases of AUFI were because of influenza. There were no culture-confirmed cases of melioidosis or enteric fever. Of AUFI admissions, 96 of 800 were because of coinfections, with leptospirosis co-infection (n = 63/800) being most frequent. False-positive scrub typhus lateral flow immunoassays were seen in 22 of 234 patients with confirmed leptospirosis. 84 of 274 dengue cases and 118 of 289 leptospirosis cases diagnosed and managed clinically (before laboratory diagnosis) were incorrect diagnoses. Clinical diagnosis of AUFI is often suboptimal, and coinfections are common in our study areas. The need for widespread availability of comprehensive molecular and serological testing of AUFI patients is highlighted.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。